Good news for insulin users: the United States FDA has approved the first generic glucagon rescue injection. Soon that vital and occasionally…
Abbott announced that it has secured CE Mark (Conformité Européenne) for its next-generation FreeStyle Libre 3 system, which is now approved…
Alarming new data shows the disturbing trend within the diabetes population in the U.S. of high unemployment and worsening health outcomes as…
The U.S. FDA has approved Lyumjev, Lilly’s new rapid-acting insulin indicated to improve glycemic control in adults with type 1 and type 2 diabetes. …
Over the past 6 weeks multiple companies have issued recalls for extended-release metformin, the oral diabetes medicine used to help control…
Abbott and Tandem Diabetes Care announced that they have finalized an agreement to develop and commercialize integrated diabetes solutions…
The U.S. FDA has announced clearance of an expanded pediatric indication for the Tandem’s t:slim X2™ insulin pump with Control-IQ™ technology…
Do you fear that you won’t be able to afford your insulin during COVID-19? The big three insulin manufacturers have assistance programs that can…
In an “unprecedented” move, the FDA has granted temporary permission for Dexcom to provide G6 continuous glucose monitoring (CGM) systems directly…
The early data on COVID-19 deaths in America is shocking and outrageous: “African Americans account for more than 40% of COVID-19 deaths in the…